Walden University NURS 6531 Week 5 Discussion Walden University NURS 6531 Week 5 Discussion Walden University NURS 6531 Week 5 Discussion Walden University NURS 6531 Week 5 Discussion Walden Universit

**** * ***************** ************* Chest ******* Case Study #2This is * *********** ********* **** ***** seen at **** clinics **** complaints ** complaints ** cough *** 4 **** and worsening ****** ** *** *** high grade ***** ****** ** ***** **** and has **** in bed **** ** *** **** *** **** Complains ** ********** ******* ******** by dyspnea ** **** non-productive ***** *** ********* ***** ********* ******* ******** magic ***** **** ****** mycostatin ************** *** Hep C ******** ********* **** ** **** ****** lives ** a ***** ******** *** *** 5’7 *** 150# *** ********** male ******* ********** *********** **** rales *** ******* *** note ********* ** breath sounds ******** *** ******************** Diagnoses1 Tuberculosis(TB): TB ** ** ******** **** ** ********** ******* **** ** ****** ** the ******** ************* ************ *** *** ****** **** ***** of the **** *** typically ******* the ***** ************** 2017) ***** ******** **** the human immunodeficiency virus(HIV) have * ****** **** of getting ************ *** **** ****** **** tuberculosis *** ***** ** HIV-infected patients ****** ** al ***** ***** risk factors ******* ********* ***** and *** **** ****** ****** ******** ** ********* tuberculosis includes ******* anorexia weight **** ***** ***** **** *** fever (Polgar-Bailey 2017)2 ********** ********* ** ** ********* ** *** ***** **** *** ** ****** ** ********* organisms and ****** *** *** ******* ** *** lungs to become fluid-filled ********* ***** It ** an acute ********* **** ******* the **** ********** ********** 2016) Common ******** ******* fever ****** ******* ***** **** or without ****** ********** dyspnea and ********* ***** **** ******* ***** There ** a *********** **** **** ******* *** pneumonia ******* *** ***** ***** does *** ******** any *********** ************* ** *** lobes3 Acute bronchitis: ***** bronchitis ** when *** ******* ** the ***** become ******** *** is ******** caused ** ******* ****** ***** **** ***** ****** ******** ******* a ********** cough malaise ********** ********* wheezing *** ********* may ** ******** ** ******** of ** upper *********** infection (Singh ***** **** ***** ******* ********** ****** are unusual *** ******** with ***** ********** and **** ******* *** *** ********** ******* ************ *********** ** * ******* granulomatous ************ ******* **** is ***** diagnosed ** ********* **** ***** **** ******** **** as ************ (Muthiah& Gamal ***** It ******* ****** ********* and ***** ******** ******** ****** and **** ** multiple ***** ****** ****** ******** ******* ***** ******* ******* ******* ******* ******* ****** ****** ***** ****** loss chest **** **** *** more ************* ***** 2018) This ***** *********** be *** ********* *** **** patient *** ** **** ** **** out ***** ******** ****** we can ************ ******** ************** H&P ****** * **** ** *********** ** ****** that this patient *** ********* ************ ** he presents **** **** ****** ******** ** ************ *** patient **** ******** **** several risk ******* *** pulmonary tuberculosis such ** being ************ ****** ** * ***** home *** **** his past ******* ** IV **** ***** ************** 2017) *** the subjective information it ***** **** **** ******* ** **** the nature ** *** cough **** ** ******* ** **** *** or *** ******* of just ****** **** ** *** non-productive It ***** **** **** **** ******* ** ********* ******* he *** ever **** ************ *** *** ********* ********* ** ** is HIV-positive *** may have *********** * ****** ********* ** the **** *** ******* **** did not ******* *** ****** history *** the ******** should **** ********** ******* ** had *** ****** history ** tuberculosis asthma ********* ********* ********** ** *** ***** ********* malignancies ***** ** ********* any treatment ** ****** **** **** **** the *********** ***** **** ** as ** *** ****** **** **** of ********* ** ********* ** themPotential ********* ******* ** ***** to ******** tuberculosis *** standard screening **** ** the ******* **** in which **** of ******** ******* *************** ** ******** ************* **** *** forearm ************** ***** **** **** ****** * ***** upon the ******* ***** ****** ** **** within ***** hours ** ***** *** * ******** ******** *** ************ ******** the ********** ****** ** ≥ *** Notably ****** ** ******** with ** have ******** reactions ** *** *** test ************** 2017) ********* *** ** ** very complex ** ** ******* on *** ******** current ******** symptoms ** *** ******* *** ********** drugs to ***** ************ ******* *** ******** ********* *********** ********** *** ********** (Polgar-Bailey ***** *** *********** drugs ******* *********** *********** streptomycin ******** capreomycin PAS ************ ************ *** gatifloxacin For ******** *** *** ** the ****** ** infection(LTBI) ***** the ********* ********* regimen ******** *** *** ** *** ***** *** nine months **** ***** dosing ** ****** child ****** ** ********** *** * ******* ***** **** ** ***** **** ****** ** * long **** ** ****** ** * medication *** it *** ** very ********* *** ******** to ****** ** **** treatment regimen ** ** our ************** ** ********* to ******* *** patient ***** *** ************* ** ******** ********* ***** and *** ** can ********* ****** ***** ****** ********* ** **** do not strictly ****** the ********* ** ****** **** ******** consulting with * ** ****** ***** ** ******** * patient **** ** ** consider ***** *************** ******** ****** **** ** ***** ***** *** ***** ******* because **** ** *** ************** drugs have been shown ** ** hepatotoxic and *** **** ** ********* ************** 2017) As *** ******* ** living in * ***** **** *** provider ****** also consider whether ** will ** **** ** ****** *** *********** ***** ********** ** *** **** ****** ** ********** *** ** **** ********* ********** ** they *** **** ********* antiviral ******* ******************************* G (2016) *** ********** *** ************** ** ********* ********* 8(1) doi:101186/s41479-016-0012-zMuthiah M * & Gamal * * ****** Sarcoidosis ********* from https://onlineepocratescom/noFrame/showPage?method=diseases&MonographId=109Polgar-Bailey * (2017) ******* 235: ************ ** * ******* * ********* * Polgar-Bailey ***** * Sandberg-Cook ***** ******* ***** A ************* ******** (5th ed pp ********** St ***** MO: ************** G C ****** ******* **** Pneumonia ** T ******* * ********* P ************* ***** * Sandberg-Cook ***** Primary ***** A collaborative ******** (5th ** pp ******** ** Louis *** ElsevierSingh A ***** Zahn * ****** Acute bronchitis ********* **** ********************************************** * Centis * ****** G D’Ambrosio L ******* * ********** * *** Migliori * B (2016) Recent ************ in *** ********* and management ** tuberculosis NPJ: ******* **** *********** ******** ***** *** doi:101038/npjpcrm201678Thompson A E ****** ********* ******* ** *** ******** ******* *********** 315(6) 626 doi:101001/jama20160320· ******* ** the ******** ******* *********** ********* ******* *** physical exams Below *** **** ** *** ** ******* ** this ********** ********************* *** *** case ********* the ******* ********* ** *** **** **** ** *** **** ** ask?· **** additional ******* **** *** ***** (Think *** allergiesmedsand so ***** that might ** ********* in arriving at **** differential ********************* **** additional ************ or ********** ***** if *** will *** ********** ***** about ************ diagnoses ******** *** **** the ******* ******* *** physical **** ****** ** your ********* Below *** ways on *** ** ******* to this ********** criterionAssessment:· ******* ** ** ** *** *** ***** these ************* ***** ** the * *** *** ** *** **** ********** ***************** ******** exam *************** **************** ********** ******* ** ********************* What are **** ************ diagnoses?· What ** **** **** likelyprimary ************ ****** ******* on ********* ********* ******* ***** ** your ************** *** **** ** *** ** ******* ** this ********** ********* Plan:· ***** ** *********** diagnosis *** **** *** treat this ********** ******* ********** ********* *** *********** care· ******* ******* ********** ****** *** *** knowledge *** ******* **** this ****** and ******** weeks' ******** ** **** ** what *** have learned **** yourpharmacologycoursesto **** *** with **** areaPatient ********* ***** Health ************ ****** additional ****** promotion strategiesbe provided ******** ******* any ************** ******** **** ***** ****** *** ********* *** ********** *****

Click here to download attached files: Walden-University-NURS-6531-Week-5-Discussion.docx